Works matching AU Numata, Shusuke


Results: 77
    1

    Schizophrenia and cognitive dysfunction.

    Published in:
    Journal of Medical Investigation, 2024, v. 71, n. 3/4, p. 205, doi. 10.2152/jmi.71.205
    By:
    • Tomoya Takeda;
    • Hidehiro Umehara;
    • Yui Matsumoto;
    • Tomohiro Yoshida;
    • Masahito Nakataki;
    • Shusuke Numata
    Publication type:
    Article
    2
    3

    Tablet-Based Cognitive and Eye Movement Measures as Accessible Tools for Schizophrenia Assessment: Multisite Usability Study.

    Published in:
    JMIR Mental Health, 2024, v. 11, p. 1, doi. 10.2196/56668
    By:
    • Morita, Kentaro;
    • Miura, Kenichiro;
    • Toyomaki, Atsuhito;
    • Makinodan, Manabu;
    • Ohi, Kazutaka;
    • Hashimoto, Naoki;
    • Yasuda, Yuka;
    • Mitsudo, Takako;
    • Higuchi, Fumihiro;
    • Numata, Shusuke;
    • Yamada, Akiko;
    • Aoki, Yohei;
    • Honda, Hiromitsu;
    • Mizui, Ryo;
    • Honda, Masato;
    • Fujikane, Daisuke;
    • Matsumoto, Junya;
    • Hasegawa, Naomi;
    • Ito, Satsuki;
    • Akiyama, Hisashi
    Publication type:
    Article
    4
    5
    6
    7

    Optimized protocol for the extraction of RNA and DNA from frozen whole blood sample stored in a single EDTA tube.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96567-2
    By:
    • Yamagata, Hirotaka;
    • Kobayashi, Ayumi;
    • Tsunedomi, Ryouichi;
    • Seki, Tomoe;
    • Kobayashi, Masaaki;
    • Hagiwara, Kosuke;
    • Chen, Chong;
    • Uchida, Shusaku;
    • Okada, Go;
    • Fuchikami, Manabu;
    • Kamishikiryo, Toshiharu;
    • Iga, Jun-ichi;
    • Numata, Shusuke;
    • Kinoshita, Makoto;
    • Kato, Takahiro A.;
    • Hashimoto, Ryota;
    • Nagano, Hiroaki;
    • Okamoto, Yasumasa;
    • Ueno, Shuichi;
    • Ohmori, Tetsuro
    Publication type:
    Article
    8
    9
    10
    11

    The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project

    Published in:
    Annals of General Psychiatry, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12991-022-00429-8
    By:
    • Kyou, Yoshitaka;
    • Yasui-Furukori, Norio;
    • Hasegawa, Naomi;
    • Ide, Kenta;
    • Ichihashi, Kayo;
    • Hashimoto, Naoki;
    • Hori, Hikaru;
    • Shimizu, Yoshihito;
    • Imamura, Yayoi;
    • Muraoka, Hiroyuki;
    • Iida, Hitoshi;
    • Ohi, Kazutaka;
    • Yasuda, Yuka;
    • Ogasawara, Kazuyoshi;
    • Numata, Shusuke;
    • Iga, Jun-ichi;
    • Tsuboi, Takashi;
    • Ochi, Shinichiro;
    • Kodaka, Fumitoshi;
    • Furihata, Ryuji
    Publication type:
    Article
    12
    13
    14
    15
    16

    ABCA7 Gene Expression and Genetic Association Study in Schizophrenia.

    Published in:
    Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 441, doi. 10.2147/NDT.S238471
    By:
    • Yamazaki, Kiyohiro;
    • Yoshino, Yuta;
    • Kawabe, Kentaro;
    • Ibuki, Tomomasa;
    • Ochi, Shinichiro;
    • Mori, Yoko;
    • Ozaki, Yuki;
    • Numata, Shusuke;
    • Iga, Jun-ichi;
    • Ohmori, Tetsuro;
    • Ueno, Shu-ichi
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23

    Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project.

    Published in:
    BMC Psychiatry, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12888-023-04908-4
    By:
    • Hashimoto, Naoki;
    • Yasui-Furukori, Norio;
    • Hasegawa, Naomi;
    • Ishikawa, Shuhei;
    • Hori, Hikaru;
    • Iida, Hitoshi;
    • Ichihashi, Kayo;
    • Miura, Kenichiro;
    • Matsumoto, Junya;
    • Numata, Shusuke;
    • Kodaka, Fumitoshi;
    • Furihata, Ryuji;
    • Ohi, Kazutaka;
    • Ogasawara, Kazuyoshi;
    • Iga, Jun-ichi;
    • Muraoka, Hiroyuki;
    • Komatsu, Hiroshi;
    • Takeshima, Masahiro;
    • Atake, Kiyokazu;
    • Kido, Mikio
    Publication type:
    Article
    24

    A significant causal association between C-reactive protein levels and schizophrenia.

    Published in:
    Scientific Reports, 2016, p. 26105, doi. 10.1038/srep26105
    By:
    • Inoshita, Masatoshi;
    • Numata, Shusuke;
    • Tajima, Atsushi;
    • Kinoshita, Makoto;
    • Umehara, Hidehiro;
    • Nakataki, Masahito;
    • Ikeda, Masashi;
    • Maruyama, Souichiro;
    • Yamamori, Hidenaga;
    • Kanazawa, Tetsufumi;
    • Shimodera, Shinji;
    • Hashimoto, Ryota;
    • Imoto, Issei;
    • Yoneda, Hiroshi;
    • Iwata, Nakao;
    • Ohmori, Tetsuro
    Publication type:
    Article
    25
    26

    Functional Genetic Variation at the NRGN Gene and Schizophrenia: Evidence From a Gene-Based Case--Control Study and Gene Expression Analysis.

    Published in:
    American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 2012, v. 159B, n. 4, p. 405, doi. 10.1002/ajmg.b.32043
    By:
    • Kazutaka Ohi;
    • Ryota Hashimoto;
    • Yuka Yasuda;
    • Motoyuki Fukumoto;
    • Hidenaga Yamamori;
    • Satomi Umeda-Yano;
    • Takeya Okada;
    • Kouzin Kamino;
    • Takashi Morihara;
    • Masao Iwase;
    • Hiroaki Kazui;
    • Shusuke Numata;
    • Masashi Ikeda;
    • Tohru Ohnuma;
    • Nakao Iwata;
    • Shu-ichi Ueno;
    • Norio Ozaki;
    • Tetsuro Ohmori;
    • Heii Arai;
    • Masatoshi Takeda
    Publication type:
    Article
    27
    28

    Predictors of life skills in people with schizophrenia.

    Published in:
    Journal of Medical Investigation, 2020, v. 67, n. 1/2, p. 75, doi. 10.2152/jmi.67.75
    By:
    • Takeo Tominaga;
    • Masahito Tomotake;
    • Tomoya Takeda;
    • Yoshinori Ueoka;
    • Tsunehiko Tanaka;
    • Shin-ya Watanabe;
    • Naomi Kameoka;
    • Masahito Nakataki;
    • Shusuke Numata;
    • Yumiko Izaki;
    • Satsuki Sumitani;
    • Hiroko Kubo;
    • Yasuhiro Kaneda;
    • Tetsuro Ohmori
    Publication type:
    Article
    29

    Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study.

    Published in:
    International Journal of Neuropsychopharmacology, 2025, v. 28, n. 4, p. 1, doi. 10.1093/ijnp/pyaf011
    By:
    • Ochi, Shinichiro;
    • Kodaka, Fumitoshi;
    • Hasegawa, Naomi;
    • Tsuboi, Takashi;
    • Ohi, Kazutaka;
    • Igarashi, Shun;
    • Fukumoto, Kentaro;
    • Iga, Jun-ichi;
    • Muraoka, Hiroyuki;
    • Iida, Hitoshi;
    • Tagata, Hiromi;
    • Kashiwagi, Hiroko;
    • Numata, Shusuke;
    • Yamagata, Hirotaka;
    • Takeshima, Masahiro;
    • Ichihashi, Kayo;
    • Hashimoto, Naoki;
    • Nagasawa, Tatsuya;
    • Nakamura, Toshinori;
    • Matsumoto, Junya
    Publication type:
    Article
    30

    PROPOSAL FOR NOVEL PATIENT CLASSIFICATION WITH ENLARGED LATERAL VENTRICLES AND COGNITIVE DECLINE BASED ON DATA-DRIVEN ANALYSIS OF NEUROIMAGING IN PSYCHIATRIC DISORDERS AND CLINICAL CHARACTERIZATION.

    Published in:
    International Journal of Neuropsychopharmacology, 2025, v. 28, p. i222, doi. 10.1093/ijnp/pyae059.390
    By:
    • Yuka Yasuda;
    • Satsuki Ito;
    • Junya Matsumoto;
    • Naohiro Okada;
    • Masaki Fukunaga;
    • Kiyotaka Nemoto;
    • Kenichiro Miura;
    • Naoki Hashimoto;
    • Kazutaka Ohi;
    • Tsutomu Takahashi;
    • Michihiko Koeda;
    • Hidenaga Yamamori;
    • Michiko Fujimoto;
    • Naomi Hasegawa;
    • Shinsuke Koike;
    • Motoaki Nakamura;
    • Go Okada;
    • Jun Miyata;
    • Shusuke Numata;
    • Toshiaki Onitsuka
    Publication type:
    Article
    31

    CHANGE OF PRESCRIPTION FOR PATIENTS WITH SCHIZOPHRENIA DURING ADMISSION: REAL-WORLD PRESCRIBING SURVEYS FROM THE EFFECTIVENESS OF GUIDELINES FOR DISSEMINATION AND EDUCATION PSYCHIATRIC TREATMENT PROJECT.

    Published in:
    International Journal of Neuropsychopharmacology, 2025, v. 28, p. i168, doi. 10.1093/ijnp/pyae059.291
    By:
    • Naoki Hashimoto;
    • Norio Yasui-Furukori;
    • Naomi Hasegawa;
    • Hikaru Hori;
    • Hitoshi Iida;
    • Kayo Ichihashi;
    • Kenichiro Miura;
    • Junya Matsumoto;
    • Shusuke Numata;
    • Fumitoshi Kodaka;
    • Ryuji Furihata;
    • Ken Inada;
    • Koichiro Watanabe;
    • Ryota Hashimoto
    Publication type:
    Article
    32

    ASSOCIATIONS OF CLOZAPINE AVAILABLE INSTITUTION AND THE DIAGNOSIS OF SUBGROUPS ABOUT TREATMENT-RESISTANT SCHIZOPHRENIA OR NOT WITH A HIGHER RATE OF ANTIPSYCHOTIC MONOTHERAPY AND LOWER OTHER CONCOMITANT PSYCHOTROPICS IN OVERALL SCHIZOPHRENIA TREATMENT: A REALWORLD NATIONWIDE STUDY

    Published in:
    International Journal of Neuropsychopharmacology, 2025, v. 28, p. i163, doi. 10.1093/ijnp/pyae059.282
    By:
    • Shinichiro Ochi;
    • Fumitoshi Kodaka;
    • Naomi Hasegawa;
    • Jun-Ichi Iga;
    • Hiroko Kashiwagi;
    • Hiroshi Komatsu;
    • Hiromi Tagata;
    • Takashi Tsuboi;
    • Shusuke Numata;
    • Hitoshi Iida;
    • Shun Igarashi;
    • Kazutaka Ohi;
    • Kentaro Fukumoto;
    • Hiroyuki Muraoka;
    • Junya Matsumoto;
    • Kenichiro Miura;
    • Shu-Ichi Ueno;
    • Koichiro Watanabe;
    • Ken Inada;
    • Ryota Hashimoto
    Publication type:
    Article
    33

    Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study.

    Published in:
    International Journal of Neuropsychopharmacology, 2022, v. 25, n. 10, p. 818, doi. 10.1093/ijnp/pyac036
    By:
    • Ochi, Shinichiro;
    • Tagata, Hiromi;
    • Hasegawa, Naomi;
    • Yasui-Furukori, Norio;
    • Iga, Jun-ichi;
    • Kashiwagi, Hiroko;
    • Kodaka, Fumitoshi;
    • Komatsu, Hiroshi;
    • Tsuboi, Takashi;
    • Tokutani, Akira;
    • Numata, Shusuke;
    • Ichihashi, Kayo;
    • Onitsuka, Toshiaki;
    • Muraoka, Hiroyuki;
    • Iida, Hitoshi;
    • Ohi, Kazutaka;
    • Atake, Kiyokazu;
    • Kishimoto, Taishiro;
    • Hori, Hikaru;
    • Takaesu, Yoshikazu
    Publication type:
    Article
    34
    35

    Clinical correlates associated with cognitive dysfunction in people with schizophrenia.

    Published in:
    Psychiatry & Clinical Neurosciences, 2012, v. 66, n. 6, p. 491, doi. 10.1111/j.1440-1819.2012.02390.x
    By:
    • Tanaka, Tsunehiko;
    • Tomotake, Masahito;
    • Ueoka, Yoshinori;
    • Kaneda, Yasuhiro;
    • Taniguchi, Kyoko;
    • Nakataki, Masahito;
    • Numata, Shusuke;
    • Tayoshi, Shinya;
    • Yamauchi, Ken;
    • Sumitani, Satsuki;
    • Ohmori, Takashi;
    • Ueno, Shu‐ichi;
    • Ohmori, Tetsuro
    Publication type:
    Article
    36
    37
    38
    39
    40

    DNA Methylation Signatures of Peripheral Leukocytes in Schizophrenia.

    Published in:
    NeuroMolecular Medicine, 2013, v. 15, n. 1, p. 95, doi. 10.1007/s12017-012-8198-6
    By:
    • Kinoshita, Makoto;
    • Numata, Shusuke;
    • Tajima, Atsushi;
    • Shimodera, Shinji;
    • Ono, Shinji;
    • Imamura, Akira;
    • Iga, Jun-ichi;
    • Watanabe, Shinya;
    • Kikuchi, Kumiko;
    • Kubo, Hiroko;
    • Nakataki, Masahito;
    • Sumitani, Satsuki;
    • Imoto, Issei;
    • Okazaki, Yuji;
    • Ohmori, Tetsuro
    Publication type:
    Article
    41

    Association Study Between the Pericentrin ( PCNT) Gene and Schizophrenia.

    Published in:
    NeuroMolecular Medicine, 2010, v. 12, n. 3, p. 243, doi. 10.1007/s12017-009-8106-x
    By:
    • Numata, Shusuke;
    • Nakataki, Masahito;
    • Iga, Jun-ichi;
    • Tanahashi, Toshihito;
    • Nakadoi, Yoshihiro;
    • Ohi, Kazutaka;
    • Hashimoto, Ryota;
    • Takeda, Masatoshi;
    • Itakura, Mitsuo;
    • Ueno, Shu-ichi;
    • Ohmori, Tetsuro
    Publication type:
    Article
    42

    Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case–control study.

    Published in:
    Neuropsychopharmacology Reports, 2024, v. 44, n. 1, p. 42, doi. 10.1002/npr2.12370
    By:
    • Lo, Tzuyao;
    • Kushima, Itaru;
    • Kimura, Hiroki;
    • Aleksic, Branko;
    • Okada, Takashi;
    • Kato, Hidekazu;
    • Inada, Toshiya;
    • Nawa, Yoshihiro;
    • Torii, Youta;
    • Yamamoto, Maeri;
    • Kimura, Ryo;
    • Funabiki, Yasuko;
    • Kosaka, Hirotaka;
    • Numata, Shusuke;
    • Kasai, Kiyoto;
    • Sasaki, Tsukasa;
    • Yokoyama, Shigeru;
    • Munesue, Toshio;
    • Hashimoto, Ryota;
    • Yasuda, Yuka
    Publication type:
    Article
    43

    Satisfaction with web‐based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.

    Published in:
    Neuropsychopharmacology Reports, 2023, v. 43, n. 1, p. 23, doi. 10.1002/npr2.12300
    By:
    • Iida, Hitoshi;
    • Okada, Tsuyoshi;
    • Nemoto, Kiyotaka;
    • Hasegawa, Naomi;
    • Numata, Shusuke;
    • Ogasawara, Kazuyoshi;
    • Miura, Kenichiro;
    • Matsumoto, Junya;
    • Hori, Hikaru;
    • Iga, Jun‐ichi;
    • Ichihashi, Kayo;
    • Hashimoto, Naoki;
    • Yamada, Hisashi;
    • Ohi, Kazutaka;
    • Yasui‐Furukori, Norio;
    • Fukumoto, Kentaro;
    • Tsuboi, Takashi;
    • Usami, Masahide;
    • Furihata, Ryuji;
    • Takaesu, Yoshikazu
    Publication type:
    Article
    44

    Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.

    Published in:
    Neuropsychopharmacology Reports, 2022, v. 42, n. 2, p. 221, doi. 10.1002/npr2.12245
    By:
    • Ogasawara, Kazuyoshi;
    • Numata, Shusuke;
    • Hasegawa, Naomi;
    • Nakataki, Masahito;
    • Makinodan, Manabu;
    • Ohi, Kazutaka;
    • Takeshima, Masahiro;
    • Tsuboi, Takashi;
    • Hashimoto, Naoki;
    • Onitsuka, Toshiaki;
    • Muraoka, Hiroyuki;
    • Hori, Hikaru;
    • Ichihashi, Kayo;
    • Inagaki, Takahiko;
    • Yasui‐Furukori, Norio;
    • Hishimoto, Akitoyo;
    • Sugiyama, Nobuhiro;
    • Fukumoto, Kentaro;
    • Nagasawa, Tatsuya;
    • Matsumoto, Junya
    Publication type:
    Article
    45

    Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.

    Published in:
    Neuropsychopharmacology Reports, 2022, v. 42, n. 1, p. 3, doi. 10.1002/npr2.12218
    By:
    • Yasui‐Furukori, Norio;
    • Muraoka, Hiroyuki;
    • Hasegawa, Naomi;
    • Ochi, Shinichiro;
    • Numata, Shusuke;
    • Hori, Hikaru;
    • Hishimoto, Akitoyo;
    • Onitsuka, Toshiaki;
    • Ohi, Kazutaka;
    • Hashimoto, Naoki;
    • Nagasawa, Tatsuya;
    • Takaesu, Yoshikazu;
    • Inagaki, Takahiko;
    • Tagata, Hiromi;
    • Tsuboi, Takashi;
    • Kubota, Chika;
    • Furihata, Ryuji;
    • Iga, Jun‐ichi;
    • Iida, Hitoshi;
    • Miura, Kenichiro
    Publication type:
    Article
    46

    Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.

    Published in:
    Neuropsychopharmacology Reports, 2021, v. 41, n. 2, p. 199, doi. 10.1002/npr2.12173
    By:
    • Numata, Shusuke;
    • Nakataki, Masahito;
    • Hasegawa, Naomi;
    • Takaesu, Yoshikazu;
    • Takeshima, Masahiro;
    • Onitsuka, Toshiaki;
    • Nakamura, Toshinori;
    • Edagawa, Reon;
    • Edo, Hiroaki;
    • Miura, Kenichiro;
    • Matsumoto, Junya;
    • Yasui‐Furukori, Norio;
    • Kishimoto, Taishiro;
    • Hori, Hikaru;
    • Tsuboi, Takashi;
    • Yasuda, Yuka;
    • Furihata, Ryuji;
    • Muraoka, Hiroyuki;
    • Ochi, Shinichiro;
    • Nagasawa, Tatsuya
    Publication type:
    Article
    47

    Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia.

    Published in:
    Neuropsychopharmacology Reports, 2020, v. 40, n. 2, p. 150, doi. 10.1002/npr2.12098
    By:
    • Kudo, Noriko;
    • Yamamori, Hidenaga;
    • Ishima, Tamaki;
    • Nemoto, Kiyotaka;
    • Yasuda, Yuka;
    • Fujimoto, Michiko;
    • Azechi, Hirotsugu;
    • Niitsu, Tomihisa;
    • Numata, Shusuke;
    • Ikeda, Manabu;
    • Iyo, Masaomi;
    • Ohmori, Tetsuro;
    • Fukunaga, Masaki;
    • Watanabe, Yoshiyuki;
    • Hashimoto, Kenji;
    • Hashimoto, Ryota
    Publication type:
    Article
    48
    49
    50

    Corrigendum: Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders.

    Published in:
    Nature Communications, 2016, v. 7, n. 4, p. 11466, doi. 10.1038/ncomms11466
    By:
    • Nakazawa, Takanobu;
    • Hashimoto, Ryota;
    • Sakoori, Kazuto;
    • Sugaya, Yuki;
    • Tanimura, Asami;
    • Hashimotodani, Yuki;
    • Ohi, Kazutaka;
    • Yamamori, Hidenaga;
    • Yasuda, Yuka;
    • Umeda-Yano, Satomi;
    • Kiyama, Yuji;
    • Konno, Kohtarou;
    • Inoue, Takeshi;
    • Yokoyama, Kazumasa;
    • Inoue, Takafumi;
    • Numata, Shusuke;
    • Ohnuma, Tohru;
    • Iwata, Nakao;
    • Ozaki, Norio;
    • Hashimoto, Hitoshi
    Publication type:
    Article